Peptidylprolyl Isomerase
Immunophilins
Tacrolimus Binding Proteins
HSP90 Heat-Shock Proteins
Amino Acid Isomerases
Cyclophilin A
Cyclophilins
Glucose-6-Phosphate Isomerase
Triose-Phosphate Isomerase
Periplasm
Tacrolimus
Carrier Proteins
Cyclosporine
Mannose-6-Phosphate Isomerase
Isomerases
Protein Disulfide-Isomerases
Steroid Isomerases
Dodecenoyl-CoA Isomerase
Amino Acid Sequence
Molecular Sequence Data
Carbon-Carbon Double Bond Isomerases
Heat-Shock Proteins
Protein Binding
Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. (1/1050)
The telomerase reverse transcriptase component (TERT) is not expressed in most primary somatic human cells and tissues, but is upregulated in the majority of immortalized cell lines and tumors. Here, we identify the c-Myc transcription factor as a direct mediator of telomerase activation in primary human fibroblasts through its ability to specifically induce TERT gene expression. Through the use of a hormone inducible form of c-Myc (c-Myc-ER), we demonstrate that Myc-induced activation of the hTERT promoter requires an evolutionarily conserved E-box and that c-Myc-ER-induced accumulation of hTERT mRNA takes place in the absence of de novo protein synthesis. These findings demonstrate that the TERT gene is a direct transcriptional target of c-Myc. Since telomerase activation frequently correlates with immortalization and telomerase functions to stabilize telomers in cycling cells, we tested whether Myc-induced activation of TERT gene expression represents an important mechanism through which c-Myc acts to immortalize cells. Employing the rat embryo fibroblast cooperation assay, we show that TERT is unable to substitute for c-Myc in the transformation of primary rodent fibroblasts, suggesting that the transforming activities of Myc extend beyond its ability to activate TERT gene expression and hence telomerase activity. (+info)R73A and H144Q mutants of the yeast mitochondrial cyclophilin Cpr3 exhibit a low prolyl isomerase activity in both peptide and protein-folding assays. (2/1050)
Previously we reported that the R73A and H144Q variants of the yeast cyclophilin Cpr3 were virtually inactive in a protease-coupled peptide assay, but retained activity as catalysts of a proline-limited protein folding reaction [Scholz, C. et al. (1997) FEBS Lett. 414, 69-73]. A reinvestigation revealed that in fact these two mutations strongly decrease the prolyl isomerase activity of Cpr3 in both the peptide and the protein-folding assay. The high folding activities found previously originated from a contamination of the recombinant Cpr3 proteins with the Escherichia coli protein SlyD, a prolyl isomerase that co-purifies with His-tagged proteins. SlyD is inactive in the peptide assay, but highly active in the protein-folding assay. (+info)Maturation-induced conformational changes of HIV-1 capsid protein and identification of two high affinity sites for cyclophilins in the C-terminal domain. (3/1050)
Viral incorporation of cyclophilin A (CyPA) during the assembly of human immunodeficiency virus type-1 (HIV-1) is crucial for efficient viral replication. CyPA binds to the previously identified Gly-Pro90 site of the capsid protein p24, but its role remained unclear. Here we report two new interaction sites between cyclophilins and p24. Both are located in the C-terminal domain of p24 around Gly-Pro157 and Gly-Pro224. Peptides corresponding to these regions showed higher affinities (Kd approximately 0.3 microM) for both CyPA and cyclophilin B than the best peptide derived from the Gly-Pro90 site ( approximately 8 microM) and thus revealed new sequence motifs flanking Gly-Pro that are important for tight interaction of peptide ligands with cyclophilins. Between CyPA and an immature (unprocessed) form of p24, a Kd of approximately 8 microM was measured, which corresponded with the Kd of the best of the Gly-Pro90 peptides, indicating an association via this site. Processing of immature p24 by the viral protease, yielding mature p24, elicited a conformational change in its C-terminal domain that was signaled by the covalently attached fluorescence label acrylodan. Consequently, CyPA and cyclophilin B bound with much higher affinities ( approximately 0.6 and 0.25 microM) to the new, i.e. maturation-generated sites. Since this domain is essential for p24 oligomerization and capsid cone formation, CyPA bound to the new sites might impair the regularity of the capsid cone and thus facilitate in vivo core disassembly after host infection. (+info)Function of WW domains as phosphoserine- or phosphothreonine-binding modules. (4/1050)
Protein-interacting modules help determine the specificity of signal transduction events, and protein phosphorylation can modulate the assembly of such modules into specific signaling complexes. Although phosphotyrosine-binding modules have been well-characterized, phosphoserine- or phosphothreonine-binding modules have not been described. WW domains are small protein modules found in various proteins that participate in cell signaling or regulation. WW domains of the essential mitotic prolyl isomerase Pin1 and the ubiquitin ligase Nedd4 bound to phosphoproteins, including physiological substrates of enzymes, in a phosphorylation-dependent manner. The Pin1 WW domain functioned as a phosphoserine- or phosphothreonine-binding module, with properties similar to those of SRC homology 2 domains. Phosphoserine- or phosphothreonine-binding activity was required for Pin1 to interact with its substrates in vitro and to perform its essential function in vivo. (+info)Identification and characterization of a 14 kDa human protein as a novel parvulin-like peptidyl prolyl cis/trans isomerase. (5/1050)
A second member of the parvulin family of peptidyl-prolyl cis/trans isomerases was identified in a human lung cDNA library. The gene encoded a protein named hPar14 that has 131 amino acid residues and a molecular mass of 13676 Da. Sequence comparison showed 34.5% identity to E. coli Par10 and 34% identity to human Pin1 (hPar18) within a C-terminal region of 87 or 120 amino acid residues, respectively. In comparison to the E. coli Par10, hPar14 possesses a N-terminal extension of 41 amino acid residues. This extension does not contain a polyproline II helix-binding motif typical of the known eukaryotic parvulins. The hPar14 does not accelerate the cis to trans interconversion of oligopeptides with side chain-phosphorylated Ser(Thr)-Pro moieties as hPin1 did. In contrast, it showed preference of an arginine residue adjacent N-terminal to proline. Northern blot analysis revealed expression of the gene within various human tissues like heart, placenta, liver, kidney and pancreas. (+info)Two distinct regions of cyclophilin B are involved in the recognition of a functional receptor and of glycosaminoglycans on T lymphocytes. (6/1050)
Cyclophilin B is a cyclosporin A-binding protein exhibiting peptidyl-prolyl cis/trans isomerase activity. We have previously shown that it interacts with two types of binding sites on T lymphocytes. The type I sites correspond to specific functional receptors and the type II sites to sulfated glycosaminoglycans. The interactions of cyclophilin B with type I and type II sites are reduced in the presence of cyclosporin A and of a synthetic peptide mimicking the N-terminal part of cyclophilin B, respectively, suggesting that the protein possesses two distinct binding regions. In this study, we intended to characterize the areas of cyclophilin B involved in the interactions with binding sites present on Jurkat cells. The use of cyclophilin B mutants modified in the N-terminal region demonstrated that the 3Lys-Lys-Lys5 and 14Tyr-Phe-Asp16 clusters are probably solely required for the interactions with the type II sites. We further engineered mutants of the conserved central core of cyclophilin B, which bears the catalytic and the cyclosporin A binding sites as an approach to localize the binding regions for the type I sites. The enzymatic activity of cyclophilin B was dramatically reduced after substitution of the Arg62 and Phe67 residues, whereas the cyclosporin A binding activity was destroyed by mutation of the Trp128 residue and strongly decreased after modification of the Phe67 residue. Only the substitution of the Trp128 residue reduced the binding of the resulting cyclophilin B mutant to type I binding sites. The catalytic site of cyclophilin B therefore did not seem to be essential for cellular binding and the cyclosporin A binding site appeared to be partially involved in the binding to type I sites. (+info)U2AF35 is encoded by an essential gene clustered in an operon with RRM/cyclophilin in Caenorhabditis elegans. (7/1050)
In most species the 3' splice site is recognized initially by an interaction between the two-subunit splicing factor U2AF with the polypyrimidine (poly(Y)) tract that results in recruitment of the U2 snRNP to the branch-point consensus just upstream. In contrast, in Caenorhabditis elegans, both the poly(Y) tract and the branch-point consensus sequences are missing, apparently replaced by the highly conserved U4CAG/R 3' splice site consensus. Nevertheless C. elegans U2AF65 is very similar to its mammalian and fly counterparts and may recognize the 3' splice site consensus. Here we report the cloning of the C. elegans U2AF35 gene, uaf-2. We show that it lacks an identifiable RS domain, which, in flies, has been shown to play a role in RNA binding, but it contains an extended glycine-rich stretch at its C-terminus. uaf-2 is in an operon with cyp-13, a gene that encodes a cyclophilin with an RRM domain at its N-terminus. We demonstrate by RNA interference that both U2AF genes, uaf-1 (which encodes U2AF65) and uaf-2, are required for viability, whereas cyp-13 is apparently not. (+info)In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A. (8/1050)
The cellular protein cyclophilin A (CypA) binds specifically to the human immunodeficiency virus type 1 (HIV-1) capsid (CA) protein and is incorporated into HIV-1 particles at a molar ratio of 1:10 (CypA/CA). Structural analysis of a CA-CypA complex suggested that CypA may destabilize interactions in the viral capsid and thus promote uncoating. We analyzed the influence of CypA on the in vitro assembly properties of wild-type (WT) CA and derivatives containing substitutions of Gly89 in the Cyp-binding loop. All variant proteins were significantly impaired in CypA binding. In the presence of CypA at a molar ratio of 1:10 (CypA/CA), WT CA assembled into hollow cylinders that were similar to those observed in the absence of CypA but slightly longer. Higher CypA concentrations inhibited cylinder formation. Variant CA proteins G89L and G89F yielded similar cylinders as the WT protein but were significantly more resistant to CypA. Cryoelectron microscopic analysis of WT cylinders assembled in the presence of CypA revealed direct binding of CypA to the outer surface. Electron diffraction patterns generated from these cylinders indicated that CypA causes local disorder. The addition of CypA to preassembled cylinders had little effect, however, and cylinders were only disrupted when incubated with a threefold molar excess of CypA for several hours. These results suggest that CypA does not efficiently destabilize CA interactions at the molar ratio observed in the virion and therefore is unlikely to serve as an uncoating factor. (+info)Peptidylprolyl Isomerase (PPIase) is an enzyme that catalyzes the cis-trans isomerization of peptidyl-prolyl bonds in proteins. This isomerization process, which involves the rotation around a proline bond, is a rate-limiting step in protein folding and can be a significant factor in the development of various diseases, including neurodegenerative disorders and cancer.
PPIases are classified into three families: cyclophilins, FK506-binding proteins (FKBPs), and parvulins. These enzymes play important roles in protein folding, trafficking, and degradation, as well as in signal transduction pathways and the regulation of gene expression.
Inhibitors of PPIases have been developed as potential therapeutic agents for various diseases, including transplant rejection, autoimmune disorders, and cancer. For example, cyclosporine A and FK506 are immunosuppressive drugs that inhibit cyclophilins and FKBPs, respectively, and are used to prevent transplant rejection.
Immunophilins are a group of intracellular proteins that have peptidyl-prolyl isomerase (PPIase) activity, which enables them to catalyze the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. They play crucial roles in protein folding, trafficking, and assembly, as well as in immunoregulation and signal transduction processes.
Two major classes of immunophilins are FK506-binding proteins (FKBPs) and cyclophilins. These proteins can bind to immunosuppressive drugs like FK506 (tacrolimus) and cyclosporin A, respectively, forming complexes that inhibit the activity of calcineurin, a phosphatase involved in T-cell activation. This interaction leads to an inhibition of immune responses and is exploited in transplantation medicine to prevent graft rejection.
Immunophilins also participate in various cellular processes, such as protein trafficking, neuroprotection, and regulation of gene expression, by interacting with other proteins or acting as chaperones during protein folding. Dysregulation of immunophilin function has been implicated in several diseases, including cancer, neurological disorders, and viral infections.
Tacrolimus binding proteins, also known as FK506 binding proteins (FKBPs), are a group of intracellular proteins that bind to the immunosuppressive drug tacrolimus (also known as FK506) and play a crucial role in its mechanism of action. Tacrolimus is primarily used in organ transplantation to prevent rejection of the transplanted organ.
FKBPs are a family of peptidyl-prolyl cis-trans isomerases (PPIases) that catalyze the conversion of proline residues from their cis to trans conformations in proteins, thereby regulating protein folding and function. FKBP12, a member of this family, has a high affinity for tacrolimus and forms a complex with it upon entry into the cell.
The formation of the tacrolimus-FKBP12 complex inhibits calcineurin, a serine/threonine phosphatase that plays a critical role in T-cell activation. Calcineurin inhibition prevents the dephosphorylation and nuclear translocation of the transcription factor NFAT (nuclear factor of activated T-cells), thereby blocking the expression of genes involved in T-cell activation, proliferation, and cytokine production.
In summary, tacrolimus binding proteins are intracellular proteins that bind to tacrolimus and inhibit calcineurin, leading to the suppression of T-cell activation and immune response, which is essential in organ transplantation and other immunological disorders.
HSP90 (Heat Shock Protein 90) refers to a family of highly conserved molecular chaperones that are expressed in all eukaryotic cells. They play a crucial role in protein folding, assembly, and transport, thereby assisting in the maintenance of proper protein function and cellular homeostasis. HSP90 proteins are named for their increased expression during heat shock and other stress conditions, which helps protect cells by facilitating the refolding or degradation of misfolded proteins that can accumulate under these circumstances.
HSP90 chaperones are ATP-dependent and consist of multiple domains: a N-terminal nucleotide binding domain (NBD), a middle domain, and a C-terminal dimerization domain. They exist as homodimers and interact with a wide range of client proteins, including transcription factors, kinases, and steroid hormone receptors. By regulating the activity and stability of these client proteins, HSP90 chaperones contribute to various cellular processes such as signal transduction, cell cycle progression, and stress response. Dysregulation of HSP90 function has been implicated in numerous diseases, including cancer, neurodegenerative disorders, and infectious diseases, making it an attractive target for therapeutic intervention.
Amino acid isomerases are a class of enzymes that catalyze the conversion of one amino acid stereoisomer to another. These enzymes play a crucial role in the metabolism and biosynthesis of amino acids, which are the building blocks of proteins.
Amino acids can exist in two forms, called L- and D-stereoisomers, based on the spatial arrangement of their constituent atoms around a central carbon atom. While most naturally occurring amino acids are of the L-configuration, some D-amino acids are also found in certain proteins and peptides, particularly in bacteria and lower organisms.
Amino acid isomerases can convert one stereoisomer to another by breaking and reforming chemical bonds in a process that requires energy. This conversion can be important for the proper functioning of various biological processes, such as protein synthesis, neurotransmitter metabolism, and immune response.
Examples of amino acid isomerases include proline racemase, which catalyzes the interconversion of L-proline and D-proline, and serine hydroxymethyltransferase, which converts L-serine to D-serine. These enzymes are essential for maintaining the balance of amino acids in living organisms and have potential therapeutic applications in various diseases, including neurodegenerative disorders and cancer.
Cyclophilin A is a type of intracellular protein that belongs to the immunophilin family. It has peptidyl-prolyl cis-trans isomerase activity, which means it helps in folding and assembling other proteins by catalyzing the cis-trans isomerization of proline residues.
Cyclophilin A is widely distributed in various tissues and cells, including immune cells such as T lymphocytes. It plays a crucial role in the immune system by binding to and activating the immunosuppressive drug cyclosporine A, which is used to prevent rejection of transplanted organs.
In addition to its role in protein folding and immunosuppression, Cyclophilin A has been implicated in various cellular processes such as signal transduction, gene expression, and apoptosis (programmed cell death). It also plays a role in viral replication, particularly of HIV-1, the virus that causes AIDS.
Cyclophilins are a family of proteins that have peptidyl-prolyl isomerase activity, which means they help with the folding and functioning of other proteins in cells. They were first identified as binding proteins for the immunosuppressive drug cyclosporine A, hence their name.
Cyclophilins are found in various organisms, including humans, and play important roles in many cellular processes such as signal transduction, protein trafficking, and gene expression. In addition to their role in normal cell function, cyclophilins have also been implicated in several diseases, including viral infections, cancer, and neurodegenerative disorders.
In medicine, the most well-known use of cyclophilins is as a target for immunosuppressive drugs used in organ transplantation. Cyclosporine A and its derivatives work by binding to cyclophilins, which inhibits their activity and subsequently suppresses the immune response.
Glucose-6-phosphate isomerase (GPI) is an enzyme involved in the glycolytic and gluconeogenesis pathways. It catalyzes the interconversion of glucose-6-phosphate (G6P) and fructose-6-phosphate (F6P), which are key metabolic intermediates in these pathways. This reaction is a reversible step that helps maintain the balance between the breakdown and synthesis of glucose in the cell.
In glycolysis, GPI converts G6P to F6P, which subsequently gets converted to fructose-1,6-bisphosphate (F1,6BP) by the enzyme phosphofructokinase-1 (PFK-1). In gluconeogenesis, the reaction is reversed, and F6P is converted back to G6P.
Deficiency or dysfunction of Glucose-6-phosphate isomerase can lead to various metabolic disorders, such as glycogen storage diseases and hereditary motor neuropathies.
Triose-phosphate isomerase (TPI) is a crucial enzyme in the glycolytic pathway, which is a metabolic process that converts glucose into pyruvate, producing ATP and NADH as energy currency for the cell. TPI specifically catalyzes the reversible interconversion of the triose phosphates dihydroxyacetone phosphate (DHAP) and glyceraldehyde 3-phosphate (G3P). This interconversion is a vital step in maintaining the balance of metabolites in the glycolytic pathway.
The reaction catalyzed by TPI is as follows:
Dihydroxyacetone phosphate ↔ Glyceraldehyde 3-phosphate
Deficiency or mutations in the gene encoding triose-phosphate isomerase can lead to a severe autosomal recessive disorder known as Triose Phosphate Isomerase Deficiency (TID). This condition is characterized by chronic hemolytic anemia, neuromuscular symptoms, and shortened lifespan.
The periplasm is a term used in the field of microbiology, specifically in reference to gram-negative bacteria. It refers to the compartment or region located between the bacterial cell's inner membrane (cytoplasmic membrane) and its outer membrane. This space contains a unique mixture of proteins, ions, and other molecules that play crucial roles in various cellular processes, such as nutrient uptake, waste excretion, and the maintenance of cell shape.
The periplasm is characterized by its peptidoglycan layer, which provides structural support to the bacterial cell and protects it from external pressures. This layer is thinner in gram-negative bacteria compared to gram-positive bacteria, which do not have an outer membrane and thus lack a periplasmic space.
Understanding the periplasmic region of gram-negative bacteria is essential for developing antibiotics and other therapeutic agents that can target specific cellular processes or disrupt bacterial growth and survival.
Tacrolimus is an immunosuppressant drug that is primarily used to prevent the rejection of transplanted organs. It works by inhibiting the activity of T-cells, which are a type of white blood cell that plays a central role in the body's immune response. By suppressing the activity of these cells, tacrolimus helps to reduce the risk of an immune response being mounted against the transplanted organ.
Tacrolimus is often used in combination with other immunosuppressive drugs, such as corticosteroids and mycophenolate mofetil, to provide a comprehensive approach to preventing organ rejection. It is available in various forms, including capsules, oral solution, and intravenous injection.
The drug was first approved for use in the United States in 1994 and has since become a widely used immunosuppressant in transplant medicine. Tacrolimus is also being studied as a potential treatment for a variety of other conditions, including autoimmune diseases and cancer.
Carrier proteins, also known as transport proteins, are a type of protein that facilitates the movement of molecules across cell membranes. They are responsible for the selective and active transport of ions, sugars, amino acids, and other molecules from one side of the membrane to the other, against their concentration gradient. This process requires energy, usually in the form of ATP (adenosine triphosphate).
Carrier proteins have a specific binding site for the molecule they transport, and undergo conformational changes upon binding, which allows them to move the molecule across the membrane. Once the molecule has been transported, the carrier protein returns to its original conformation, ready to bind and transport another molecule.
Carrier proteins play a crucial role in maintaining the balance of ions and other molecules inside and outside of cells, and are essential for many physiological processes, including nerve impulse transmission, muscle contraction, and nutrient uptake.
Cyclosporine is a medication that belongs to a class of drugs called immunosuppressants. It is primarily used to prevent the rejection of transplanted organs, such as kidneys, livers, and hearts. Cyclosporine works by suppressing the activity of the immune system, which helps to reduce the risk of the body attacking the transplanted organ.
In addition to its use in organ transplantation, cyclosporine may also be used to treat certain autoimmune diseases, such as rheumatoid arthritis and psoriasis. It does this by suppressing the overactive immune response that contributes to these conditions.
Cyclosporine is available in capsule, oral solution, and injectable forms. Common side effects of the medication include kidney problems, high blood pressure, tremors, headache, and nausea. Long-term use of cyclosporine can also increase the risk of certain types of cancer and infections.
It is important to note that cyclosporine should only be used under the close supervision of a healthcare provider, as it requires regular monitoring of blood levels and kidney function.
Mannose-6-Phosphate Isomerase (MPI) is an enzyme that catalyzes the interconversion between mannose-6-phosphate and fructose-6-phosphate, which are both key metabolites in the glycolysis and gluconeogenesis pathways. This enzyme plays a crucial role in maintaining the balance between these two metabolic pathways, allowing cells to either break down or synthesize glucose depending on their energy needs.
The gene that encodes for MPI is called MPI1 and is located on chromosome 4 in humans. Defects in this gene can lead to a rare genetic disorder known as Mannose-6-Phosphate Isomerase Deficiency or Congenital Disorder of Glycosylation Type IIm, which is characterized by developmental delay, intellectual disability, seizures, and various other neurological symptoms.
Isomerases are a class of enzymes that catalyze the interconversion of isomers of a single molecule. They do this by rearranging atoms within a molecule to form a new structural arrangement or isomer. Isomerases can act on various types of chemical bonds, including carbon-carbon and carbon-oxygen bonds.
There are several subclasses of isomerases, including:
1. Racemases and epimerases: These enzymes interconvert stereoisomers, which are molecules that have the same molecular formula but different spatial arrangements of their atoms in three-dimensional space.
2. Cis-trans isomerases: These enzymes interconvert cis and trans isomers, which differ in the arrangement of groups on opposite sides of a double bond.
3. Intramolecular oxidoreductases: These enzymes catalyze the transfer of electrons within a single molecule, resulting in the formation of different isomers.
4. Mutases: These enzymes catalyze the transfer of functional groups within a molecule, resulting in the formation of different isomers.
5. Tautomeres: These enzymes catalyze the interconversion of tautomers, which are isomeric forms of a molecule that differ in the location of a movable hydrogen atom and a double bond.
Isomerases play important roles in various biological processes, including metabolism, signaling, and regulation.
Aldose-ketose isomerases are a group of enzymes that catalyze the interconversion between aldoses and ketoses, which are different forms of sugars. These enzymes play an essential role in carbohydrate metabolism by facilitating the reversible conversion of aldoses to ketoses and vice versa.
Aldoses are sugars that contain a carbonyl group (a functional group consisting of a carbon atom double-bonded to an oxygen atom) at the end of the carbon chain, while ketoses have their carbonyl group located in the middle of the chain. The isomerization process catalyzed by aldose-ketose isomerases helps maintain the balance between these two forms of sugars and enables cells to utilize them more efficiently for energy production and other metabolic processes.
There are several types of aldose-ketose isomerases, including:
1. Triose phosphate isomerase (TPI): This enzyme catalyzes the interconversion between dihydroxyacetone phosphate (a ketose) and D-glyceraldehyde 3-phosphate (an aldose), which are both trioses (three-carbon sugars). TPI plays a crucial role in glycolysis, the metabolic pathway that breaks down glucose to produce energy.
2. Xylulose kinase: This enzyme is involved in the pentose phosphate pathway, which is a metabolic route that generates reducing equivalents (NADPH) and pentoses for nucleic acid synthesis. Xylulose kinase catalyzes the conversion of D-xylulose (a ketose) to D-xylulose 5-phosphate, an important intermediate in the pentose phosphate pathway.
3. Ribulose-5-phosphate 3-epimerase: This enzyme is also part of the pentose phosphate pathway and catalyzes the interconversion between D-ribulose 5-phosphate (an aldose) and D-xylulose 5-phosphate (a ketose).
4. Phosphoglucomutase: This enzyme catalyzes the reversible conversion of glucose 1-phosphate (an aldose) to glucose 6-phosphate (an aldose), which is an important intermediate in both glycolysis and gluconeogenesis.
5. Phosphomannomutase: This enzyme catalyzes the reversible conversion of mannose 1-phosphate (a ketose) to mannose 6-phosphate (an aldose), which is involved in the biosynthesis of complex carbohydrates.
These are just a few examples of enzymes that catalyze the interconversion between aldoses and ketoses, highlighting their importance in various metabolic pathways.
Protein Disulfide-Isomerases (PDIs) are a family of enzymes found in the endoplasmic reticulum (ER) of eukaryotic cells. They play a crucial role in the folding and maturation of proteins by catalyzing the formation, breakage, and rearrangement of disulfide bonds between cysteine residues in proteins. This process helps to stabilize the three-dimensional structure of proteins and is essential for their proper function. PDIs also have chaperone activity, helping to prevent protein aggregation and assisting in the correct folding of nascent polypeptides. Dysregulation of PDI function has been implicated in various diseases, including cancer, neurodegenerative disorders, and diabetes.
Steroid isomerases are a class of enzymes that catalyze the interconversion of steroids by rearranging various chemical bonds within their structures, leading to the formation of isomers. These enzymes play crucial roles in steroid biosynthesis and metabolism, enabling the production of a diverse array of steroid hormones with distinct biological activities.
There are several types of steroid isomerases, including:
1. 3-beta-hydroxysteroid dehydrogenase/delta(5)-delta(4) isomerase (3-beta-HSD): This enzyme catalyzes the conversion of delta(5) steroids to delta(4) steroids, accompanied by the oxidation of a 3-beta-hydroxyl group to a keto group. It is essential for the biosynthesis of progesterone, cortisol, and aldosterone.
2. Aromatase: This enzyme converts androgens (such as testosterone) into estrogens (such as estradiol) by introducing a phenolic ring, which results in the formation of an aromatic A-ring. It is critical for the development and maintenance of female secondary sexual characteristics.
3. 17-beta-hydroxysteroid dehydrogenase (17-beta-HSD): This enzyme catalyzes the interconversion between 17-keto and 17-beta-hydroxy steroids, playing a key role in the biosynthesis of estrogens, androgens, and glucocorticoids.
4. 5-alpha-reductase: This enzyme catalyzes the conversion of testosterone to dihydrotestosterone (DHT) by reducing the double bond between carbons 4 and 5 in the A-ring. DHT is a more potent androgen than testosterone, playing essential roles in male sexual development and prostate growth.
5. 20-alpha-hydroxysteroid dehydrogenase (20-alpha-HSD): This enzyme catalyzes the conversion of corticosterone to aldosterone, a critical mineralocorticoid involved in regulating electrolyte and fluid balance.
6. 3-beta-hydroxysteroid dehydrogenase (3-beta-HSD): This enzyme catalyzes the conversion of pregnenolone to progesterone and 17-alpha-hydroxypregnenolone to 17-alpha-hydroxyprogesterone, which are essential intermediates in steroid hormone biosynthesis.
These enzymes play crucial roles in the biosynthesis, metabolism, and elimination of various steroid hormones, ensuring proper endocrine function and homeostasis. Dysregulation or mutations in these enzymes can lead to various endocrine disorders, including congenital adrenal hyperplasia (CAH), polycystic ovary syndrome (PCOS), androgen insensitivity syndrome (AIS), and others.
Dodecenoyl-CoA isomerase is an enzyme that catalyzes the conversion of dodecenoyl-CoA to trans-2-dodecenoyl-CoA in the beta-oxidation pathway of fatty acid metabolism. This enzyme plays a crucial role in the breakdown and energy production from long-chain fatty acids in the body. The isomerization reaction facilitated by this enzyme helps to introduce a double bond at a specific position during the degradation process, allowing for further oxidation and energy release.
Protein folding is the process by which a protein molecule naturally folds into its three-dimensional structure, following the synthesis of its amino acid chain. This complex process is determined by the sequence and properties of the amino acids, as well as various environmental factors such as temperature, pH, and the presence of molecular chaperones. The final folded conformation of a protein is crucial for its proper function, as it enables the formation of specific interactions between different parts of the molecule, which in turn define its biological activity. Protein misfolding can lead to various diseases, including neurodegenerative disorders such as Alzheimer's and Parkinson's disease.
An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.
Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.
Carbon-carbon double bond isomerases are a class of enzymes that catalyze the conversion of one geometric or positional isomer of a molecule containing a carbon-carbon double bond into another. These enzymes play an important role in the metabolism and biosynthesis of various biological compounds, including fatty acids, steroids, and carotenoids.
There are several types of carbon-carbon double bond isomerases, each with their own specific mechanisms and substrate preferences. Some examples include:
1. Ene/Yne Isomerases: These enzymes catalyze the conversion of a carbon-carbon double bond that is conjugated to an alkene or alkyne group into a new double bond location through a series of [1,5]-sigmatropic shifts.
2. Cis-Trans Isomerases: These enzymes catalyze the interconversion of cis and trans geometric isomers of carbon-carbon double bonds. They are often involved in the biosynthesis of complex lipids and other biological molecules where specific stereochemistry is required for proper function.
3. Peroxisomal Isomerases: These enzymes are involved in the metabolism of fatty acids with very long chains (VLCFA) in peroxisomes. They catalyze the conversion of cis-delta(3)-double bonds to trans-delta(2)-double bonds, which is a necessary step for further processing and degradation of VLCFAs.
4. Retinal Isomerases: These enzymes are involved in the visual cycle and catalyze the conversion of 11-cis-retinal into all-trans-retinal during the process of vision.
5. Carotenoid Isomerases: These enzymes are involved in the biosynthesis of carotenoids, which are pigments found in plants and microorganisms. They catalyze the conversion of cis-configured carotenoids into trans-configured forms, which have higher stability and bioactivity.
In general, carbon-carbon double bond isomerases function by lowering the energy barrier for a specific isomerization reaction, allowing it to occur under physiological conditions. They often require cofactors or other proteins to facilitate their activity, and their regulation is critical for maintaining proper metabolism and homeostasis in cells.
Heat-shock proteins (HSPs) are a group of conserved proteins that are produced by cells in response to stressful conditions, such as increased temperature, exposure to toxins, or infection. They play an essential role in protecting cells and promoting their survival under stressful conditions by assisting in the proper folding and assembly of other proteins, preventing protein aggregation, and helping to refold or degrade damaged proteins. HSPs are named according to their molecular weight, for example, HSP70 and HSP90. They are found in all living organisms, from bacteria to humans, indicating their fundamental importance in cellular function and survival.
Protein binding, in the context of medical and biological sciences, refers to the interaction between a protein and another molecule (known as the ligand) that results in a stable complex. This process is often reversible and can be influenced by various factors such as pH, temperature, and concentration of the involved molecules.
In clinical chemistry, protein binding is particularly important when it comes to drugs, as many of them bind to proteins (especially albumin) in the bloodstream. The degree of protein binding can affect a drug's distribution, metabolism, and excretion, which in turn influence its therapeutic effectiveness and potential side effects.
Protein-bound drugs may be less available for interaction with their target tissues, as only the unbound or "free" fraction of the drug is active. Therefore, understanding protein binding can help optimize dosing regimens and minimize adverse reactions.
Carbohydrate epimerases are a group of enzymes that catalyze the interconversion of specific stereoisomers (epimers) of carbohydrates by the reversible oxidation and reduction of carbon atoms, usually at the fourth or fifth position. These enzymes play important roles in the biosynthesis and modification of various carbohydrate-containing molecules, such as glycoproteins, proteoglycans, and glycolipids, which are involved in numerous biological processes including cell recognition, signaling, and adhesion.
The reaction catalyzed by carbohydrate epimerases involves the transfer of a hydrogen atom and a proton between two adjacent carbon atoms, leading to the formation of new stereochemical configurations at these positions. This process can result in the conversion of one epimer into another, thereby expanding the structural diversity of carbohydrates and their derivatives.
Carbohydrate epimerases are classified based on the type of substrate they act upon and the specific stereochemical changes they induce. Some examples include UDP-glucose 4-epimerase, which interconverts UDP-glucose and UDP-galactose; UDP-N-acetylglucosamine 2-epimerase, which converts UDP-N-acetylglucosamine to UDP-N-acetylmannosamine; and GDP-fucose synthase, which catalyzes the conversion of GDP-mannose to GDP-fucose.
Understanding the function and regulation of carbohydrate epimerases is crucial for elucidating their roles in various biological processes and developing strategies for targeting them in therapeutic interventions.